We are live on ! Find out more
PBC

Pavion Blue Capital Portfolio holdings

AUM $248M
1-Year Est. Return 22.79%
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
+22.79%
3 Year Est. Return
+77.62%
5 Year Est. Return
+100.27%
10 Year Est. Return
–
AUM
$241M
AUM Growth
+$6.21M
Cap. Flow
-$1.15M
Cap. Flow %
-0.48%
Top 10 Hldgs %
46.56%
Holding
110
New
9
Increased
9
Reduced
42
Closed
3

Top Buys

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$237K
2
CAT icon
Caterpillar
CAT
+$224K
3
FCX icon
Freeport-McMoran
FCX
+$217K
4
MRK icon
Merck
MRK
+$205K
5
CB icon
Chubb
CB
+$202K

Top Sells

Rank Stock Value
1
DEO icon
Diageo
DEO
+$767K
2
NVDA icon
NVIDIA
NVDA
+$383K
3
UPS icon
United Parcel Service
UPS
+$317K
4
SMG icon
ScottsMiracle-Gro
SMG
+$258K
5
PFE icon
Pfizer
PFE
+$249K

Sector Composition

Rank Sector Weight
1 Financials 23.64%
2 Consumer Staples 18.61%
3 Technology 16.67%
4 Communication Services 10.99%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBTYK icon
76
Liberty Global Class C
LBTYK
$3.49B
$347K 0.14%
31,464
-6,859
-18% -$76.3K
CSCO icon
77
Cisco
CSCO
$479B
$346K 0.14%
4,497
– –
C icon
78
Citigroup
C
$226B
$342K 0.14%
2,934
– –
NEE icon
79
NextEra Energy
NEE
$177B
$337K 0.14%
4,196
– –
VTI icon
80
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$330K 0.14%
983
– –
VEU icon
81
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$317K 0.13%
4,306
– –
TMO icon
82
Thermo Fisher Scientific
TMO
$220B
$309K 0.13%
533
-18
-3% -$10.2K
GILD icon
83
Gilead Sciences
GILD
$165B
$288K 0.12%
2,345
– –
BDX icon
84
Becton Dickinson
BDX
$48.2B
$272K 0.11%
1,400
– –
QCOM icon
85
Qualcomm
QCOM
$176B
$269K 0.11%
1,570
– –
COR icon
86
Cencora
COR
$61.2B
$261K 0.11%
772
– –
FCX icon
87
Freeport-McMoran
FCX
$97.5B
$254K 0.11%
+5,000
New +$217K
EPD icon
88
Enterprise Products Partners
EPD
$81.7B
$254K 0.11%
7,916
– –
VEA icon
89
Vanguard FTSE Developed Markets ETF
VEA
$236B
$250K 0.1%
3,995
– –
STRL icon
90
Sterling Infrastructure
STRL
$16.7B
$245K 0.1%
800
– –
SO icon
91
Southern Company
SO
$107B
$237K 0.1%
2,715
– –
BR icon
92
Broadridge
BR
$19B
$235K 0.1%
1,053
– –
IYH icon
93
iShares US Healthcare ETF
IYH
$3.54B
$231K 0.1%
3,550
– –
CAT icon
94
Caterpillar
CAT
$387B
$231K 0.1%
+403
New +$224K
MRK icon
95
Merck
MRK
$318B
$229K 0.1%
+2,179
New +$205K
PGR icon
96
Progressive
PGR
$125B
$228K 0.09%
1,000
-145
-13% -$32.7K
CLX icon
97
Clorox
CLX
$12.7B
$227K 0.09%
2,250
– –
CARR icon
98
Carrier Global
CARR
$52.8B
$223K 0.09%
4,219
– –
KMB icon
99
Kimberly-Clark
KMB
$36.5B
$219K 0.09%
+2,169
New +$237K
DE icon
100
Deere & Co
DE
$168B
$217K 0.09%
467
– –
1 2 3
4
5

Similar funds

MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return
TAM
Tabor Asset Management New York $249M AUM 48.59% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Step Capital Management Singapore $249M AUM
AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return

Pavion Blue Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Pavion Blue Capital held 110 positions worth $241M, up 2.6% from $235M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pavion Blue Capital's Q4 2025 filing shows 9 new, 9 increased, 42 reduced and 3 closed positions. Its largest new stake was Kimberly-Clark: 2,169 shares worth $219K. The largest sale was Diageo, an estimated $767K.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Consumer Staples and Technology.

  • Pavion Blue Capital's largest Q4 2025 buy was Kimberly-Clark: 2,169 shares worth $219K.
  • Pavion Blue Capital added most to Nike in Q4 2025, an estimated $194K increase.
  • Pavion Blue Capital's biggest Q4 2025 reduction was Diageo, cutting an estimated $767K.
  • Pavion Blue Capital fully exited Pfizer in Q4 2025, selling an estimated $249K.
  • Pavion Blue Capital's ten largest holdings make up 47% of its $241M portfolio in Q4 2025.
  • Pavion Blue Capital opened 9 new positions and closed 3 in Q4 2025.
  • Pavion Blue Capital's portfolio value rose 2.6% quarter-over-quarter to $241M.

Based on Pavion Blue Capital's 13F filing for Q4 2025, filed 27 Jan 2026.